InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: None

Tuesday, 06/13/2017 9:17:21 PM

Tuesday, June 13, 2017 9:17:21 PM

Post# of 108192
"Aratana has completed enrollment of a pivotal field safety study related to AT-104, their proposed treatment for canine osteosarcoma. They anticipate conditional licensure by the United States Department of Agriculture-USDA, in the second half of 2017."

From a recent SA article.

https://seekingalpha.com/article/4080942-aratana-might-want-grab-shares-rapidly-expanding-companion-animal-market?v=1497331340&comments=show
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News